Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 78 results.
LastUpdate Updated on 22/11/2026 [07:41:00]
pdfxls
previousPage Results 75 to 78 of 78  

Nucleic acid detection kit for on-site detection of multiple pathogens and application of nucleic acid detection kit

Publication No.:  CN122466115A 28/07/2026
Applicant: 
BEIJING INTEGRATED BIOSYSTEMS CO LTD
THE 7TH MEDICAL CENTER OF PLA GENERAL HOSPITAL
\u5317\u4EAC\u4E2D\u79D1\u751F\u4EEA\u79D1\u6280\u6709\u9650\u516C\u53F8
\u4E2D\u56FD\u4EBA\u6C11\u89E3\u653E\u519B\u603B\u533B\u9662\u7B2C\u4E03\u533B\u5B66\u4E2D\u5FC3
CN_122466115_A

Absstract of: CN122466115A

The invention provides a nucleic acid detection kit for on-site detection of multiple pathogens and application, and relates to the technical field of molecular biology. The invention provides a nucleic acid detection kit for on-site detection of multiple pathogens, which comprises a primer probe for detecting staphylococcus aureus, a primer probe for detecting pseudomonas aeruginosa, a primer probe for detecting legionella pneumophila and a primer probe for detecting haemophilus influenzae, the detection kit provided by the invention can achieve relatively high detection sensitivity to four pathogenic bacteria, and the specificity and repeatability of the detection kit both meet the detection requirements. The kit disclosed by the invention has relatively high stability and can be stored for more than one year at normal temperature.

Specific primer combination for detecting human exposure potential pathogenic bacteria in glacier environment

Publication No.:  CN122466117A 28/07/2026
Applicant: 
NORTHWEST INST OF ECO ENVIRONMENT AND RESOURCES CAS
\u4E2D\u56FD\u79D1\u5B66\u9662\u897F\u5317\u751F\u6001\u73AF\u5883\u8D44\u6E90\u7814\u7A76\u9662
CN_122466117_PA

Absstract of: CN122466117A

The invention relates to a specific primer combination for detecting human exposed potential pathogenic bacteria in a glacier environment. The specific primer combination comprises a Klebsiella pneumoniae primer Seq1, a Pseudomonas aeruginosa primer Seq4, a Clostridium difficile primer Seq7 and a Legionella pneumophila primer Seq10, wherein the target gene of the Klebsiella pneumoniae primer Seq1 is wzc, the target gene of the Pseudomonas aeruginosa primer Seq4 is sigX, the target gene of the Clostridium difficile primer Seq7 is tcdB, and the target gene of the Legionella pneumophila primer Seq10 is mip. The method has the characteristics of high specificity and multiple targets, and can be effectively used for detection and risk identification of potential pathogenic bacteria in glacier environment samples.

B cell conservative epitope peptide of campylobacter jejuni MapA protein and application of B cell conservative epitope peptide in detection

Nº publicación: CN122464966A 28/07/2026

Applicant:

YANGZHOU UNIV
\u626C\u5DDE\u5927\u5B66

CN_122464966_PA

Absstract of: CN122464966A

The invention discloses a B cell conservative epitope peptide of a campylobacter jejuni MapA protein and application of the B cell conservative epitope peptide in detection. According to the invention, an LP9 coding gene is inserted into a Peg pilus operon gene, and is introduced into an S9H inert vector bacterium, so that a recombinant strain capable of functionally exhibiting and expressing an LP9 epitope on the surface of a thallus is obtained. The recombinant strain can specifically recognize and combine with an antibody generated by campylobacter jejuni infection or immunization, and has no cross reaction with healthy serum and other positive serum of enteropathogenic bacteria. The LP9 epitope directly mediated antibody agglutination detection system constructed on the basis of the recombinant strain can detect a specific antibody 3 days after a mouse is infected with campylobacter jejuni, is rapid and convenient, and is expected to become a technology and platform for campylobacter jejuni infection diagnosis, on-site screening and monitoring.

traducir